IQGAP2 has been proposed to be a tumour suppressor and its expression is downregulated when IQGAP1 is overexpressed in hepatocellular [37,48,49] carcinoma, while IQGAP3 shows oncogenic properties. Here, IQGAP1 is linked to carcinoma.